Natixis’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,317
Closed -$1.27M 1113
2023
Q4
$1.27M Buy
+20,317
New +$1.27M 0.01% 464